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The p400 Complex Is an Essential
E1A Transformation Target
1994; Howe and Bayley, 1992). We show here that this
doublet is composed of p400, a novel SWI2/SNF2 family
member, and TRRAP/PAF400, a c-myc- and p/CAF-
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Residues 25–36 of E1A Are Necessary
Summary for Its Transforming Activity
E1A residues 26–35 were originally considered dispens-
Here, we report the identification of a new E1A binding able for its transforming activity (Jelsma et al., 1989;
protein complex that is essential for E1A-mediated Whyte et al., 1988), and deletion of this region failed to
transformation. Its core component is a SWI2/SNF2- affect its p300/CBP and pocket protein binding proper-
related, 400 kDa protein (p400). Other components ties. However, the same domain constitutes an essential
include the myc- and p/CAF-associated cofactor, binding site for a heretofore uncharacterized 400 kDa
TRRAP/PAF400, the DNA helicases TAP54/, actin-like protein(s) (Barbeau et al., 1994; Bayley and Mymryk,
proteins, and the human homolog of the Drosophila En- 1994). Recent results support a major role for E1A resi-
hancer of Polycomb protein. An E1A mutant, defective dues 25–36 in E1A  ras focus forming activity (L. Deleu
in p400 binding, is also defective in transformation. and H. Land, personal communication). In keeping with
Certain p400 fragments partially rescued this pheno- this finding, we confirm that, at limiting concentrations,
type, underscoring the role of E1A-p400 complex for- E1A transforming activity is linked to the presence of
mation in the E1A transforming process. Furthermore, an intact aa 26–35 region (Figure 1A). At higher E1A
E1A and c-myc each alter the subunit composition concentrations, dependence on this segment was lim-
of p400 complexes, implying that physiological p400 ited or absent (Figure 1A), but the defect in E1A/400
complex formation contributes to transformation sup- kDa protein binding was also much less apparent (data
pression. not shown). These findings suggest that the aa 26–35
segment interacts with a specific target protein(s) or
Introduction protein complex(es), that, in turn, contributes to E1A
transforming activity.
The adenovirus E1A oncoprotein elicits abnormal bio-
logical effects, including promotion of cell cycle pro- The E1A-Associated 400 kDa Band Is a Doublet
gression, immortalization, blockade of differentiation, Composed of Two Unique Proteins
and, in concert with activated ras, transformation of In a prior report, it was shown that a p300-directed
primary rodent cells (for review, see Bayley and Mymryk, monoclonal antibody, RW144, coprecipitated p300/CBP
1994). To achieve these effects, it targets certain cellular and a 400 kDa band(s) from metabolically labeled cells.
proteins, such as the tumor suppressor, pRB, and the Similarly, in Western blot analyses, RW144 recognized
transcriptional coactivator/signal integrating proteins, a 400 kDa protein in -E1A immunoprecipitates (IPs).
p300 and CBP. E1A binding leads to modification of the To confirm these observations, we incubated extracts
activities of these proteins (for review, see Nevins, 1992; of metabolically labeled 293 cells (which synthesize E1A)
Goodman and Smolik, 2000). For example, pRb and with either -E1A or RW144 antibodies. Figure 1B re-
p300/CBP function influences local chromatin structure, veals that RW144 precipitated both p300 and a 400
and E1A binding to these proteins likely perturbs the kDa polypeptide, and both proteins comigrated with
chromatin and, hence, the transcription modulating ef- the E1A-precipitated p300 and the 400 kDa species,
fects of these proteins. respectively (Figure 1B, see lanes 2 and 1). These data
In addition to pocket proteins and p300/CBP, E1A suggest that p400 is either a p300/CBP homolog or is
interacts with a 400 kDa protein doublet (Barbeau et al., a novel E1A binding protein that shares an epitope(s)
with p300/CBP.
Binding to the previously described, E1A-associated7 Correspondence: david_livingston@dfci.harvard.edu
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Figure 1. Attenuated Transformation Activity
of E1A Deletion Mutant 26-35 Correlates
with a Defect in 400 kDa Protein Binding
(A) The E1A mutant 26-35 is attenuated in
focus forming activity. REF cells were trans-
fected with increasing quantities of wt E1A,
E1A26-35 and activated ras expression
plasmids, as indicated. Focus formation was
quantified after 10 days. The results of a rep-
resentative experiment are shown.
(B) The p300-directed, RW144 monoclonal
antibody precipitated a 400 kDa species that
comigrates with the E1A-associated 400 kDa
molecule. Cell extracts of metabolically la-
beled 293 cells were subjected to IP with the
indicated antibodies.
(C) P400 and p300/CBP interact with different
segments of E1A. U2OS cells were transiently
transfected with expression plasmids encod-
ing either wt or mutant E1A species. The cor-
responding cell extracts were immunoprecip-
itated with the E1A-specific antibody, M73.
Western blot analysis was performed using
the p300-directed, p400-crossreactive anti-
body, RW144. E1A expression levels were
controlled by Western blotting with M73.
(D) The RW144 antibody directly binds to the upper species of the RW144-associated 400 kDa doublet. U2OS cells were metabolically labeled
and lysates were IPed with RW144, RW128 (-p300), or control (-HA) antibody. RW144 precipitates were denatured and reprecipitated with
RW144.
400 kDa has been shown to require certain N-terminal tive 400 kDa interaction partner from these extracts were
then immobilized on an RW144 affinity matrix. BoundE1A sequences (Barbeau et al., 1994; Howe and Bayley,
1992). When analyzed by -E1A IP (M73)/Western blot- proteins, eluted under denaturing conditions, were reap-
plied to a second RW144 column to achieve purificationting (RW144), E1A binding of the RW144-reactive 400
kDa band was dependent upon the integrity of residues of p400 and elimination of the lower 400 kDa band (Fig-
ure 1D). The eluate from the second RW144 matrix was26–35 (Figure 1C, lane 3), while p300/CBP binding to
E1A was unaffected by this deletion (Figure 1C, compare separated by SDS-PAGE, and the stained p400 protein
excised from the gel. To purify the faster migrating 400lanes 2 and 3). These results strongly suggest that the
E1A-associated and the RW144-reactive 400 kDa pro- kDa band, proteins eluted from the first RW144 column
were separated by SDS-PAGE and the lower band ex-teins are the same polypeptide(s). Deletion of E1A resi-
dues 2–11 or an Arg-Gly mutation at position 2 abolished cised. Both protein bands (3–5 g) were subjected to
microsequencing.p300/CBP but not p400 binding (Figure 1C, lanes 7 and
8), thus, underscoring the view that p400 and p300/ Sequence analysis of the p400 band by ion trap mass
spectrometry resulted in the identification of five pep-CBP interact with different (albeit partially overlapping)
segments of the E1A N-terminal region. tides that all mapped to a single, partial cDNA clone
(GenBank accession number U80743), identified in aUnder certain electrophoretic conditions, the E1A-
associated 400 kDa species migrated as a closely screen for cDNAs with long CAG trinucleotides repeats.
This cDNA maps to human chromosome 12q24.33 (Mar-spaced doublet (Barbeau et al., 1994). We similarly ob-
served a closely spaced 400 kDa doublet in RW144 IPs golis et al., 1997).
Sequence analysis of the lower 400 kDa species byof metabolically labeled cell lysates (Figure 1D, lane
3). To further define the nature of the two bands, we Edman degradation resulted in seven peptide se-
quences that all match the protein sequence for TRRAP/immunoprecipitated metabolically labeled cell extract
with RW144 (Figure 1D, lane 3), eluted the precipitated PAF400, a myc-associated, transcriptional coactivator
(TRRAP; McMahon et al., 1998), as well as a compo-polypeptides from the Protein-A Sepharose beads after
denaturation, and reprecipitated the eluate with RW144 nent of the p/CAF histone acetyltransferase complex
(PAF400, Vassilev et al., 1998).(Figure 1D, lane 4). This strategy (IP/ReIP) revealed that
only the upper 400 kDa band bound directly to RW144,
implying a difference in structure between these two
Cloning and Initial Characterization of p400species. This finding also suggested that one band of
A full-length human p400 cDNA was assembled by cDNAthe 400 kDa doublet coprecipitated with the other in the
library screening, RACE (rapid amplification of cDNApresence of RW144. We have labeled the upper band
ends), and homology alignment with fragments of the“p400,” consistent with the term previously used for the
murine homolog. This cDNA encodes a 3124 residueE1A-associated 400 kDa protein.
protein that is ubiquitously expressed, as revealed by
semiquantitative RT-PCR and in situ hybridization (dataPurification of Both 400 kDa Proteins
not shown). In vitro translated FLAG-tagged p400 comi-HeLa nuclear extracts were depleted of p300/CBP by
immunoaffinity chromatography, and p400 and its puta- grated with endogenous p400 in IPs generated with dif-
p400 Complex and E1A Transformation
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Figure 2. Structure of Recombinant of p400
(A) Schematic depiction of the p400 primary structure. The SWI2/SNF2 homology domain has been defined in green.
(B) Comparison of the ATPase/helicase-like domain of various SWI2/SNF2 family members. The spacer region of p400 and SRCAP has been
deleted to permit relevant sequence alignment. Identical residues are denoted in green; conserved residues are noted in gray. Further identity
between p400 and SRCAP is highlighted in yellow.
ferent p400-specific monoclonal antibodies (data not members is shown in Figure 2B. A potentially important
feature of p400 and SRCAP is the lack of a conservedshown). Thus, clonal p400 likely corresponds to the en-
dogenous p400 protein. DEXH/D motif (p400 residues 1183–1186) that is present
in all other known SWI2/SNF2 proteins. Mutational anal-The predicted motif structure of p400 is represented
schematically in Figure 2A. It contains the distinct signa- ysis has linked this motif to the enzymatic function of
some RNA helicases (Pause and Sonenberg, 1992). Theture motifs that constitute the DNA-dependent ATPase/
helicase-like domain of SWI2/SNF2 family members. An importance of this motif in SWI2/SNF2 chromatin re-
modeling function has not been analyzed, although it isunusual feature of this domain is the presence of an
500 residue linker sequence separating it into two sub- conceivable that its absence affects the expression of
p400 enzymatic activity.segments. A spacer also exists within the SWI2/SNF2
homology domain of the CBP-associated protein,
SRCAP (Johnston et al., 1999). TRRAP/PAF400 Associates with Both E1A
and p400Homology between p400 and other SWI2/SNF2 pro-
teins is mainly restricted to the ATPase/helicase-like In addition to identifying p400 as a component of the
E1A-associated 400 kDa doublet (Figure 1C), we askedsegment. An alignment of p400 with the ATPase/heli-
case-like domain of representative SWI2/SNF2 family whether TRRAP/PAF400, which associates with p400 in
Cell
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tion between p400 and TRRAP is independent of the
presence of p300/CBP, given that anti-p400 IPs lacked
these proteins (data not shown).
P400, Like TRRAP/PAF400, Is Associated
with c-myc and Is a Component
of a Multiprotein Complex
We next asked whether p400, like its interaction partner,
TRRAP/PAF400, associates with myc. GST-myc binding
assays, performed with a U2OS cell extract, revealed
that p400 binds specifically to myc in vitro (Figure 4A,
lane 2). Moreover, an interaction between endogenous
myc and p400 was apparent in IPs generated with two,
different c-myc antibodies (Figure 4B, lanes 3 and 4)
as well as an antibody against the c-myc dimerization
partner, max (lane 6). Thus, in keeping with the knowl-
edge that p400 and TRRAP/PAF400 stably interact with
one another, p400 also interacts, directly or indirectly,
with c-myc.
TRRAP/PAF400 is a subunit of the human p/CAF com-
plex (Vassilev et al. 1998), as well as the recently de-
scribed TIP60 complex (Ikura et al., 2000). Western blot
analysis of p/CAF (Ogryzko et al., 1998) and TIP60 com-
plexes revealed the presence of p400 in the TIP60 but
not the p/CAF complex (Figure 4C). As expected,
TRRAP/PAF400 was present in both complexes (Figure
4C, lower segment). Thus, while both complexes contain
TRRAP/PAF400, only one of them (TIP60) contains p400.
It, therefore, appears that only a fraction of endogenous
TRRAP/PAF400 is bound to p400. By contrast, analysis
of IPs, generated with a panel of different p400-specific
Figure 3. P400 and TRRAP/PAF400 Constitute the E1A-Associated antibodies, suggested that the majority of endogenous
p400 Protein Doublet p400 molecules exist in complex with TRRAP/PAF400
(A) TRRAP/PAF400 represents the bottom band of the E1A-associ- (data not shown).
ated p400 doublet. Extracts of metabolically labeled 293 cells were
The above-noted results indicate that p400 is a com-subjected to IP with the indicated antibodies. Anti-E1A IPs from 293
ponent of at least one multiprotein complex. To furthercells were denatured and subjected to re-IP with RW144, -TRRAP/
analyze this, we purified p400 from HeLa cells, express-PAF400, or control serum.
(B) TRRAP/PAF400 and p400 interact with E1A. Extracts of 293 ing FLAG-tagged p400 under the control of a tetracy-
cells were subjected to IP with -E1A, -p300, RW144, or control cline-responsive promoter. Recombinant p400 and its
antibody. Western blots were analyzed with -p400 monoclonal associated proteins were purified from a nuclear extract
antibody (PO212) (upper panel) or TRRAP/PAF400 polyclonal rabbit
by immunoaffinity chromatography and specific epi-antiserum (lower panel).
tope-containing peptide elution. A specific and repro-(C) E1A binding to TRRAP/PAF400 is dependent on E1A residues
ducible pattern of bands copurified with tagged p40026–35. Extracts of U2OS cells, transiently expressing wt E1A or E1A
mutant protein, were subjected to E1A-specific IP. Western blots in the relevant eluate (Figure 4D).
were analyzed with RW144 (upper panel) or-TRRAP/PAF400 (lower MS/MS spectrometric analysis identified a doublet
panel). migrating at55 kDa as the DNA helicases, TAP54 and
 (Figures 4D and 4E), also present in TIP60 complexes.
TAP54 and  are identical to the myc-associatedHeLa cell extracts, represents the other protein species
in the E1A-associated 400 kDa doublet. E1A IPs from TIP48/49 helicases (Wood et al., 2000). Similar analysis
further revealed two other 50 kDa proteins to be actinmetabolically labeled 293 cell extract (Figure 3A, lane
5) were denatured, eluted from the immune beads, and and the actin-like protein, BAF53 (Figure 4D), also com-
ponents of the TIP60 complex and generic componentssubsequently re-IPed with TRRAP/PAF400-specific an-
tibody (lane 8), control serum (lane 7), or RW144 (lane of some SWI/SNF complexes (Cairns et al., 1998; Pe-
terson et al., 1998; Zhao et al., 1998). Thus, p400 associ-6). TRRAP/PAF400 was recovered from the precipitate,
indicating that it is a component of the E1A-bound 400 ates with a number of proteins also present in the TIP60
complex, consistent with the prior finding that purifiedkDa doublet. The interaction between E1A, TRRAP/
PAF400, and p400 was further confirmed by Western TIP 60 complexes contain p400.
To search for common subunits in the TIP60, p/CAF,blotting of -E1A IPs with TRRAP/PAF400- and p400-
specific antibodies (Figure 3B). The data indicate that and p400 complexes, we probed Western blots of puri-
fied complexes with specific antibodies against TIP60,TRRAP/PAF400 represents the lower band of the E1A-
and the RW144-bound 400 kDa doublet. Furthermore, TAP54, p400, p/CAF, and PAF400/TRAP (Figure 4E).
P/CAF was, as expected, absent in TIP60 and p400TRRAP/PAF400 binding to E1A requires, like p400, resi-
dues 26–35 of E1A (Figure 3C). In addition, the interac- complex preparations. Surprisingly, we failed to detect
p400 Complex and E1A Transformation
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Figure 4. p400 Is a Component of a Multipro-
tein Complex
(A) P400 associates with myc in vitro. U2OS
cell extracts were incubated with GST, GST/
myc, or GST/E1A (4 g) in the presence of
Glutathione-Sepharose beads. Precipitated
proteins were separated by SDS-PAGE, blot-
ted, and the membrane probed with the p300/
p400 antibody, RW144.
(B) Complex formation between p400 and
c-myc/max in vivo. HeLa cell extracts were
incubated with either -p400 (PO212), -p300
(RW128), -myc (N262 and C19), or -max
(C17) antibodies. To achieve specificity con-
trol, C17 and C19 were incubated with their
respective cognate peptides prior to IP.
Western blots were analyzed with -p300/
p400 (RW144, upper panel) or -myc (9E10,
lower panel) antibody.
(C) p400 is a component of the TIP60 but not
the p/CAF complex. HeLa cell extract was
precipitated with -p300 or -p400 specific
antibody. The precipitates were resolved by
SDS-PAGE, in parallel with aliquots of puri-
fied TIP60 and p/CAF complexes (400 ng).
Western blot analysis was performed with
RW144 or -TRRAP/PAF400 antibody, as in-
dicated.
(D) Identification of subunits present in the
p400 complex. The p400 complex was puri-
fied by -FLAG affinity purification from HeLa
cell nuclear extract, containing FLAG-tagged recombinant p400, expressed under the control of a tetracycline-responsive promoter. 300 ng
of the antibody column eluate was separated and silverstained. Characterized bands are named, other bands that were reproducibly detected
in different preparations are marked with an asterisk.
(E) Comparison of the p/CAF, TIP60, and p400 complexes. After Western blotting, approximately 300 ng of purified p/CAF complex, TIP60
complex and p400 complex were variously probed with -p400 (PO28), -TRRAP/PAF400, -p/CAF, -TIP60, and -TAP54 antibodies.
TIP60 protein in the p400 complex (Figure 4E), and, ble to analyze the enzymatic function of intact, pure, in
vivo synthesized p400. However, a bacterially ex-unlike purified TIP60 complexes, p400 complexes con-
tained only minimal traces of HAT activity (M.F., T.I., and pressed, p400 ATPase domain (residues 950–2048)
lacked demonstrable ATPase activity. Although sugges-Y.N., unpublished observation).
The data suggest that endogenous p400 exists in mul- tive, this result might not be meaningful, because this
incomplete p400 species might lack sufficient confor-tiple complexes and that these complexes have certain
unique subunits and functions. To address this possibil- mational elements to be enzymatically active.
We measured the ATPase activities of immunoaffinityity further, we have embarked upon the biochemical
purification of endogenous p400 complexes from HeLa purified, epitope-tagged p400-containing complexes
synthesized in both HeLa and Sf9 cells. Figure 5B de-nuclear extracts. Our observations to date suggest that,
in these extracts, there is biochemical heterogeneity picts the results of a representative experiment, demon-
strating concentration-dependent ATPase activity of theamong p400 complexes (R.D., M.F., and D.L., unpub-
lished data), thus supporting the findings reported here. recombinant complexes from these two sources. As
controls, a FLAG-affinity purified fraction, prepared fromThe functional significance of the existence of these
different complexes remains to be deciphered. HeLa cells void of recombinant p400, and a FLAG-affin-
ity purified fraction of Sf9 producing abundant quantities
of a truncated version of p400 (1–1044/m) were rela-The p400 Complex Displays ATPase
tively inactive. P400 (1-1044/m) contains a largeand Helicase Activities
N-terminal deletion, carries a point mutation in the puta-To assess the enzymatic properties of p400, we puri-
tive ATP binding site, and is defective in TAP54/ bind-fied recombinant p400 from insect (Sf9) cells infected
ing (Figure 5A, lane 5). These data suggest that thewith a p400-encoding baculovirus. Interestingly, insect
ATPase activity of the purified, p400-containing multi-TAP54/ copurified with human p400 (Figure 5A, lane
protein complex is, at least in part, a product of bound4), implying that p400 interacts effectively with both ho-
TAP54/.mologous and heterologous TAP54. A p400 deletion/
The ATPase activity of purified human and SF9 p400point mutant (1-1044/m) failed to bind TAP54/ (Fig-
complexes was intrinsically high before addition of DNAure 5A, lane 5), underscoring the specificity of the p400/
and was minimally stimulated by exogenously addedTAP54 interaction.
DNA. As has been previously reported for the yeastThus far, we have been unable to dissociate biochemi-
Ino80 complex (Shen et al., 2000), a complex with prop-cally the TAP54/ doublet from wt p400, except under
denaturing conditions. Therefore, it has not been possi- erties analogous to those of the p400 complex, it is likely
Cell
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Figure 5. ATPase and Helicase Activity of the p400 Complex
(A) p400 complexes purified from HeLa and Sf9 cells. Nuclear extracts of HeLa cells expressing and not expressing FLAG-epitope-tagged
p400 as well as Sf9 cells expressing recombinant p400 or a mutant p400 species (1-1044/m) were subjected to FLAG-affinity purification.
Approximately 600 ng of each complex were separated by SDS-PAGE. Western blots were probed with -FLAG and -TAP54 antibodies.
(B) The p400 complex displays ATPase activity. Increasing quantities of p400 complex (approximately 100, 200, and 300 ng of wt, mock
generated, and dl1-1044/m complexes) prepared from HeLa or from Sf9 cells, as indicated, were assayed for ATPase activity. Each reaction
mixture was () or was not () supplemented with dsDNA and stopped after 20 min of incubation. TAP54, TAP54, and TAP54/ heterodimers
(50 ng) served as positive controls.
(C) The p400 complex displays helicase activity. The ability of purified p400 complexes to displace a [-32P]GTP-labeled oligonucleotide from
a circular template served as a measure of p400 complex helicase activity. The p400 complex purified from Hela and Sf9 cells, p400 1-1044/m
from Sf9 cells, and a mock preparation were each assayed for helicase activity. To assess the enzymatic nature of the observed reactions,
the HeLa p400 preparation was incubated in the presence and absence of 25 mM EDTA. As a positive control for helicase activity, the standard
template was incubated with purified TIP60 complex. Reaction mixtures lacking enzyme and containing denatured template are depicted as
controls for nonspecific effects.
that DNA copurifies with the p400 complex and serves remodeling activity on either mononucleosomal or poly-
nucleosomal templates (data not shown).as an “intrinsic” stimulator of complex-associated
ATPase function. Similarly, the TIP60 complex showed
high intrinsic ATPase activity without addition of DNA
Nature of the E1A-p400 and TAP54/-p400(Ikura et al., 2000). In this regard, preincubation of the
InteractionsHeLa-purified p400 complex with DNaseI resulted in
To address the structure-function relationships underly-reduced ATPase activity (data not shown).
ing the TAP54/-p400 and E1A-p400 interactions, weRecombinant p400-containing p400 complexes, puri-
generated a panel of p400 fragments fused to a Gal DNAfied from HeLa and Sf9 cells, were also assayed for DNA
binding domain (serving as an epitope) and transientlyhelicase activity. Both exhibited DNA unwinding activity
expressed them in HeLa and 293 cells. The HeLa cell(Figure 5C, lanes 4 and 7), and, similar to the case of
the ATPase activity, this activity, too, correlated with extracts were IPed with -TAP54 antibodies and the
293 extracts with -E1A. Coprecipitation of p400 frag-the presence of TAP54/. Specifically, the p400 mutant
(1–1044/m), defective in TAP54/ binding, was also ments was assayed by Western blotting. Figure 6A sche-
matically depicts the p400 sequences necessary fordefective in helicase activity (Figure 5C, lane 8). Thus far,
p400 complexes have not displayed in vitro chromatin these interactions. The data suggest that the p400 frag-
p400 Complex and E1A Transformation
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shown). The same fragment also constitutes the p400-
TRRAP/PAF400 interaction surface (data not shown).
Since the E1A-p400 interaction appears to be mediated
by TRRAP/PAF400 (data not shown), it is likely to be
indirect. These data also imply that TRRAP/PAF400
binds directly to E1A.
P400/E1A Complex Formation Plays a Major Role
in the E1A Transforming Process
To investigate the role of p400-containing complexes
in the E1A-mediated transforming process, we asked
whether overproduction of specific p400 fragments
modifies E1A transforming activity. Attention was fo-
cused on the SWI2/SNF2-related region that contains
the E1A interaction sites (see above). Notably, three
p400 fragments (residues 848–1099, 951–1365, and
1854–2008) significantly enhanced the transforming po-
tential of E1A. A fragment corresponding to the SWI/
SNF “spacer” unit (residues 1334–1860) was inactive
(Figure 6B).
Since multiple SWI/SNF domain fragments can inter-
act with E1A (see above), we asked whether the transfor-
mation enhancing effects of the three segments that
were active in this regard could be ascribed to direct/
indirect sequestration of wt E1A. In particular, we per-
formed an experiment to determine whether the relevant
p400 fragments would complement, at least in part, the
transformation-defective E1A deletion mutant, 26–35,
in focus formation. This E1A species cannot bind effi-Figure 6. p400 Is an Essential E1A Transformation Target
ciently to intact p400 or any of its fragments (see above).(A) Identification of the p400-E1A and p400-TAP54/ binding sites
Indeed, the p400 fragments—856–1104, 951–1365, andwithin p400. Various p400 fragments were fused to a Gal4 DNA
binding domain (GAL/DBD) and transiently expressed in 293 or HeLa 1854–2008—all restored transforming activity to E1A dl
cells. Cell extracts were subjected to IP with -E1A (M73; 293 cell 26–35 while the spacer-containing fragment (1334–
extract) or TAP54-specific antibody (HeLa cell extract). Western 1860) was inactive. These results strongly suggest that
blots were probed with -Gal4-specific antibody (RK5C1). The re-
these fragments, operating free of an E1A binding re-sults of these assays are presented schematically.
quirement, interfere with normal p400 function in an(B) Specific p400 fragments enhance the ability of E1A  ras to
E1A-like manner. Thus, E1A-p400-TRRAP/PAF400 com-transform rat embryo fibroblasts. 1.5 g of E1A and 1.5 g of ras
expression vector were cotransfected with 7 g of vector encoding plex formation is likely a key element in the E1A trans-
the relevant GAL/DBD-p400 fusion protein, as indicated. After culti- forming process.
vation under reduced serum conditions for 14 days, foci were
counted. The data were normalized to the number of foci observed
E1A and myc Target Different Componentsin an E1A  ras transformation experiment in which the Gal/DNA
of the p400 Complexbinding fragment devoid of any p400 sequences was ectopically
expressed. This control level of focus formation was artificially set E1A interferes with pRB tumor suppressor function, at
at 100%. The results of three separate experiments are summarized. least in part, by “displacing” E2F from the pRB pocket
(C) Specific p400 fragments partially restore the ability of E1A 26- domain, thereby interfering with pRB transcription re-
35 to transform rat embryonic fibroblasts in the presence of ras. 1.5 pression function. In light of the aforementioned results,
g of the E1A 26-35 expression vector and 1.5 g of the above-
we asked whether E1A interferes in a similar way with thenoted ras expression vector were cotransfected together with 7 g
interaction of p400 with any of its associated proteins.of the relevant GAL/DBD-p400 fusion protein (or with unfused GAL/
DBD as a control). Foci were counted after cultivation under reduced In particular, since E1A and TAP54/ interact with a
serum conditions for 14 days. The data were normalized with the common region of the p400 SWI2/SNF2 homology do-
number of foci observed after cotransfection of E1A26-35  ras, main, we asked whether E1A-p400 complexes contain
plus unfused Gal/DBD, set at 100%. The results of a representative TAP54/.
experiment are shown.
An extract of HeLa cells synthesizing HA-tagged
TAP54 (V.O., T.I., and Y.N., unpublished data) was incu-
bated, in parallel, with equivalent quantities of GST,ment containing the SWI2/SNF2-like N-terminal region
(residues 951–1365) is sufficient for binding to TAP54/. GST/myc, and GST/E1A. Bound proteins were analyzed
by Western blotting. Consistent with recent observa-Two segments of the SWI2/SNF2 homology domain
co-IPed with E1A: Importantly, one fragment, residues tions on the c-myc/TAP54/[Tip48/49] interaction, only
GST/myc recruited recombinant TAP54 in this assay951–1365, is also the above-noted TAP54 binding frag-
ment (see above). The other (residues 1333–2048) con- (Figure 7A). However, in keeping with the results shown
in Figure 4A, GST/myc and GST/E1A both bound p400tains the spacer and the C-terminal region.
A third p400 segment (aa 2033–2484) interacted with in the same experiment (data not shown). These results
imply that E1A and TAP54 cannot interact simultane-E1A when assayed in vivo but not in vitro (data not
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Figure 7. Different Forms of the p400 Com-
plex Associate with E1A and myc
(A) E1A excludes TAP54 from the p400 com-
plex. GST, GST/myc, and GST/E1A were in-
cubated with lysates of HeLa cells synthesiz-
ing recombinant HA-tagged TAP54 in the
presence of Glutathione-Sepharose beads.
Western blots of the bead-bound, elec-
trophoresed proteins were probed with
-TAP54.
(B) Enhancer of Polycomb coelutes with
p400. Nuclear extracts of HeLa cells, induced
to express recombinant p400, were incu-
bated with -FLAG affinity-agarose and
bound proteins eluted with FLAG peptide. El-
uates were electrophoresed, and Western
blots were probed with -FLAG (M5) or -EPc
(Enhancer of Polycomb) antibody.
(C) EPc associates with E1A. 293 cell lysates
were subjected to IP with RW144 (-p300/
p400), -E1A, or -p400 antibody. Western
blot analysis was performed with RW144 or
-EPc antiserum.
(D) EPc is not a component of the myc-asso-
ciated p400 complex. HeLa cells were tran-
siently transfected with recombinant, HA-tagged EPc or empty vector. Cell extracts were incubated with either -myc, -max, or -HA (F7)
antibody. Western blots were probed with RW144 (-p300/p400) or -HA (12CA5) antibody.
ously with p400. Thus, E1A either excludes p400 com- strong SWI2/SNF2 homology. SWI2/SNF2 ATPases are
vital participants in chromatin remodeling events linkedplexes containing TAP54, or it promotes the displace-
ment of TAP54 from (otherwise intact) p400 structures. to processes including transcription, recombination,
and DNA repair. The complex also contains TRRAP/The NuA4 complex contains components homolo-
gous to those identified in the TIP60 complex, e.g., Esa1, PAF400, a myc-associated cofactor that was previously
shown to be essential for myc-induced transformation.Tra1, and ARPs (Allard et al., 1999; Galarneau et al.,
2000). Recently, a homolog of Drosophila Enhancer of Both proteins, TRRAP/PAF400 and p400, represent the
previously described 400 kDa, E1A binding doublet.Polycomb (EPc), a protein associated with epigenetic
chromatin modulation, was identified in the NuA4 com- Other components of the p400 complex include the DNA
plex (Galarneau et al., 2000). Likewise, TIP60 complexes helicases TAP54/, -actin, actin-like BAF53, and the
contain the human homolog of EPc (V.O., T.I., and Y.N., mammalian homolog of Drosophila Enhancer of Poly-
unpublished data). Western blot analysis with an EPc- comb. In Drosophila, EPc participates in epigenetic si-
specific antiserum revealed the presence of human EPc lencing mechanisms, like position effect variegation
in p400 complexes that had been FLAG-affinity purified (Sinclair et al., 1998).
from Hela cells synthesizing FLAG-tagged p400 (Figure Our results link the binding of E1A to p400 complexes
7B). Furthermore, endogenous EPc coprecipitated with and the E1A transforming mechanism. Specifically, certain
E1A and endogenous p400, but not with p300, in ex- p400 fragments stimulated wt E1A transforming activity
tracts of 293 cells, suggesting that EPc is a component and rescued the transforming defect of E1A26-35, a mu-
of an E1A-bound p400 complex (Figure 7C). Finally, p400 tant deficient in p400 complex binding. Furthermore, p400
was present in an EPc co-IP (Figure 7D), and EPc copre- complexes contain TRRAP/PAF400, which has been
cipitated with both p400 and TAP54 in TAP54 IPs (data shown previously to interact with myc and to participate
not shown). Taken together, these data strongly suggest in the myc and E1A transforming process. Analogous
that EPc is a member of the p400 complex. to the case of p400 fragments and E1A, TRRAP/PAF400
To determine whether c-myc/p400 complexes also fragments served as modulators of myc transforming
contain EPc, recombinant epitope-tagged murine EPc activity (McMahon et al., 1998).
was transiently expressed in HeLa cells. Lysates were Upon binding to E1A, the p400 complex likely under-
exposed to specific myc/max IP. Importantly, myc/EPc goes one or more specific perturbations that contribute
co-IP was not detected, despite the presence of readily to E1A transforming action. The observation that E1A
detected c-myc/p400 coprecipitation (Figure 7D, lower and TAP54 interact with the same segment of p400 and
panel). By contrast, p400 coprecipitated with trans- that E1A binding apparently displaces TAP54 from p400
fected, recombinant EPc (Figure 7D, lane 3). Thus, analo- complexes or selects against its presence in these struc-
gous to the E1A-TAP54 situation, either c-myc targets tures suggests that E1A binding modulates TAP54 activ-
a form of the p400 complex that does not contain EPc ity. Previous results implied that TAP54 helicase activity
or c-myc/ p400 complex formation is associated with was inapparent until it joined TIP60 complexes (Ikura et
displacement of EPc. al., 2000). The E1A transforming process might, there-
fore, include the suppression of TAP54 enzymatic activ-
Discussion ity. The binding of a second oncoprotein, c-myc, also
influenced the protein composition of the p400 complex.
Myc-associated p400 complexes lacked the EPc pro-Reported here are the properties of a multiprotein com-
plex whose central component is a 400 kDa protein with tein, although they contain TAP54 (Wood et al., 2000)
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and other members of the complex. Thus, both c-myc complex, we failed to detect TIP60 in p400 complex
and E1A either select partially, albeit specifically, as- preparations. These results suggest that related com-
sembled complexes or selectively displace at least one plexes containing certain common components and
member of an intact p400 complex. In both cases, the lacking others coexist in the cell. Conceivably, the poly-
effect on p400 subunit composition correlates with E1A/ peptide composition of various complexes changes with
c-myc transforming activity. Interestingly, the protein(s) cell behavior, e.g., during the cell cycle, following cell
missing from the p400 complex in the two cases was stress, during development/differentiation, and/or after
different. In this regard, TAP54 appears to be a neces- DNA damage.
sary participant in myc-mediated transformation (Wood In considering the biochemical functions of the p400
et al., 2000). It is therefore not surprising that myc-bound complex, it seems likely that it plays a role in the control
p400 complexes contain this protein. of DNA mechanics and chromatin remodeling events.
Selective protein loss from a multisubunit complex Despite the absence of direct biochemical proof for this
by E1A and other viral oncoproteins is a well known view, the presence of a SWI2/SNF2 family member,
phenomenon, i.e., the loss of various E2F species from paired DNA helicases, and EPc, a known controller of
nuclear pocket protein-containing complexes (Nevins, chromatin structure, constitutes a sizeable body of sug-
1992). As with E1A and c-myc binding to p400 com- gestive, albeit circumstantial evidence.
plexes, selective protein loss from pocket protein-con- Recent findings have established a link between de-
taining complexes correlated with oncoprotein trans- fective chromatin remodeling and human cancer devel-
forming activity. opment. Mutations in the hSNF5/INI1 subunit of a human
Myc also interacts with the histone acetyltransferase, SWI/SNF complex have been observed in the tumor
Gcn5, and a myc-Gcn5 fusion protein can partially re- cells of pediatric rhabdoid tumor (Versteege et al., 1998),
store the ability of certain mutant myc species to trans- and of chronic myelogenous leukemia (Grand et al.,
form rodent cells (McMahon et al., 2000). Yeast Gcn5 1999). Since the p400 complex has now been identified
forms a complex with the TRRAP/PAF400 yeast homo- as a key E1A and c-myc transformation target, it would
log, Tra1 (Saleh et al., 1998), and p/CAF can associate not be surprising to find that, like the cases of other
with TRRAP/PAF400 (Vassilev et al., 1998). Therefore, E1A binding proteins (pRB, p300/CBP), one or more of
one might hypothesize that myc interacts with at least its components has human tumor suppressing activity.
two different TRRAP/PAF400-containing complexes, In that context, it will be interesting to determine whether
the p400 complex and the GCN5/TRRAP/PAF400 com- the gene encoding p400 or any other component of the
plex. It is conceivable that targeting of both complexes p400 complex is repeatedly mutated in human cancer.
is essential for myc-dependent transformation.
The p400 complex displayed ATPase and helicase
Experimental Proceduresactivities. These functions are, at least in part, contrib-
uted by TAP54/. The binding site for TAP54 maps to
Cell Culturethe N-terminal segment of the p400 SWI2/SNF2-homol-
The tetracycline-responsive, recombinant p400 cell line was gener-
ogy domain, and TAP54/p400 complex formation did not ated in HeLa Tet-Off cells (Clontech) by transfection with a pTre2
inhibit TAP54/ helicase activity. Rather, recombinant vector (Clontech) encoding full-length, FLAG-tagged p400 and a
TAP54/ heterodimers are inactive as a helicase and hygromycin resistance marker plasmid in a 20:1 ratio using FUGENE
as a transfection reagent (Roche) and then grown in DMEM supple-appear to require ancillary components present in a
mented with 10% FBS, 2 g/ml tetracycline, 150 g/ml hygromycin,TIP60 complex to be activated (Ikura et al., 2000). Thus,
and 350 g/ml Geneticin (G418, GibcoBRL). Recombinant p400 wasfor the appearance of helicase activity, binding of
induced within 48–72 hr after tetracycline withdrawal. Sf9 insect
TAP54/ to p400 might be crucial. cells (Gibco BRL) were grown at a density of 1–2.5  106 cells/ml
Members of the SWI2/SNF2 family induce widespread and infected with baculovirus encoding recombinant wt or mutant
changes in the rearrangement of the DNA wrapped p400 protein according to the manufacturer’s instructions (BAC-
TO-BAC Baculovirus Expression System, GibcoBRL).around histone octamers. The p400 complex has, thus
far, proven to be inactive in this assay, though the molec-
ular basis for this observation is unclear. One possibility
Protein Purification and Peptide Sequencingis that the purified complex lacks a key component nec- Monoclonal antibodies RW128 and RW144 (Eckner et al., 1994) were
essary for eliciting in vitro chromatin remodeling activity. covalently coupled to Protein A-Sepharose beads. HeLa cells (50
A second is that the presence of EPc in the complex g) were lysed in NET-N/[170] buffer (20 mM Tris/HCl [pH 8.0], 170
may have an inhibitory effect, since EPc is suspected mM NaCl2, and 0.5% NP-40), supplemented with a protease inhibitor
cocktail (Roche), and incubated twice with RW128-affinity beadsof promoting a state of transcriptional silencing and
for 5 hr at 4C. The supernatant was incubated with RW144-coupledthe formation of heterochromatin (Shimono et al., 2000;
matrix overnight at 4C. Beads were washed with NET-N[500] andSinclair et al., 1998). Thus, one wonders whether one
NET-N[100], and proteins eluted by boiling in 50 mM Tris/HCl, (pH
role of the Epc-containing p400 complex is to block 8.0), 1% SDS, 5 mM EDTA, and 5 mM DTT. Further purification of
chromatin remodeling, behaving in this regard like Poly- p400 was performed by reapplying the eluate, diluted 1:10 in NET-
comb group proteins (Shao et al., 1999). Third, we can- N[170], to a second aliquot of RW144 matrix. Eluted proteins were
not exclude the possibility that the lack of chromatin then resolved by SDS-PAGE, and the p400 band was excised from
the gel for subsequent sequencing. TRRAP/PAF400 was preparedremodeling activity by the purified complex is due to a
for microsequencing by elution of protein from the first RW144-lack of intrinsic p400 ATPase activity.
coupled matrix followed by preparative SDS-PAGE. Excised p400The p400 complex shares components with the re-
and TRRAP/PAF400 gel bands were analyzed for protein sequence
cently described TIP60-associated complex, including at the Harvard Microchemistry Facility. Detailed information will be
TRRAP/PAF400, TAP54/, actin/actin-related proteins communicated upon request. MS/MS analysis of individual subunits
(Ikura et al., 2000), and EPc (V.O., T.I., and Y.N., unpub- of the p400 complex was performed at the DFCI Molecular Biology
Core Facility.lished data). Though p400 is a component of the TIP60
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P400 Cloning scribed (Land, 1995). 106 cells were transfected with 1.5 g of an
E1A and an activated ras expression plasmid and 7 g of a plasmidPeptide information obtained from p400 sequence analysis mapped
to a partial cDNA clone, GenBank accssion number: U80743 (Mar- encoding a relevant Gal-p400 fusion protein using FUGENE. After
48 hr, transfected cells were split 1:8 and cultivated for 10–14 daysgolis et al., 1997). This sequence information was used for screening
a random-primed HeLa cDNA library (Clontech) applying standard in DMEM containing 5% FBS.
hybridization methods. A resulting partial cDNA clone was further
extended using a combinatorial approach of cDNA library screening DNA Helicase and ATPase Assays
and RACE (rapid amplification of cDNA ends), using the 5	 RACE The helicase substrate was prepared, and helicase reactions were
System (GibcoBRL) in combination with Advantage HF-2 Polymer- performed as described in Drapkin et al. (1996) using a 35-mer
ase Mix (Clontech). Detailed information on cloning steps and prim- oligonucleotide (5	-ATTAAGTTGGGTAACGCCAGGGTTTTCCCAG
ers are available on request. TCAC-3	) annealed to single-stranded M13mp18. Reactions were
resolved by electrophoresis in an 8% native polyacrylamide gel
Expression Plasmids containing 25% glycerol at 90 V for 3 hr at 4C. The substrate and
A p400 full-length cDNA product bearing an N-terminal FLAG epi- single-stranded products were visualized by autoradiography.
tope was assembled in a pCMV- expression plasmid (Eckner et To measure the ATPase activity of p400 complexes and
al., 1994). P400 cDNA fragments were amplified using standard PCR TAP54/, approximately 50, 100, and 150 ng of p400 protein (quan-
techniques and subcloned in frame into a pMMP vector (gift from titated by silverstaining) and 50 ng of TAP54, , and / were
R. Mulligan, HHMI) bearing a segment encoding an N-terminal Gal4 incubated with or without 100 nM DNA and 100 M ATP, as de-
DNA binding domain (GAL/DBD) (Kung et al., 2000). scribed (Phelan et al., 1999). The reaction mixture was analyzed by
To generate recombinant baculoviruses encoding wt and mutant PEI chromatography, and the percentage of free [32-P]phosphate
p400, the corresponding cDNAs were cloned in pTre (GibcoBRL). was measured.
The p400 deletion mutation, 1-1044 N/m, was generated with the
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